跳至主要内容
临床试验/SLCTR/2018/016
SLCTR/2018/016尚未招募3 期

The efficacy and safety of N-acetylcysteine in patients with acute kidney injury complicating leptospirosis – A randomized controlled clinical trial

ational Research Council of Sri Lanka0 个研究点开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female subjects aged 18 years and above
  • 2. Confirmed diagnosis of leptospirosis as determined by Leptospirosis Immunochromatography test and Leptospirosis Microscopic Agglutination Test
  • 3. Acute kidney injury, defined based on Kidney Disease Improving Global Outcomes criteria: (KDIGO criteria).

排除标准

  • 1. Patients with clinical or serological evidence of co-infection with dengue or Hanta virus
  • 2. Patients on nitrates and other antioxidant medication including vitamin E supplementation
  • 3. Superadded pulmonary hemorrhages as a complication of leptospirosis
  • 4. Patients with acute liver dysfunction defined as: clinical evidence of encephalopathy and or evidence of coagulopathy with INR>1.5 with significant jaundice and a total serum bilirubin level of >100 µmol/L
  • 5. Patients in cardiogenic or septic shock as a complication of leptospirosis
  • 6. Pregnancy – All female patients will undergo urinary beta HcG testing prior to inclusion

研究者

发起方
ational Research Council of Sri Lanka

相似试验